Skip to main content
OpenTrials

Clinical trial condition

Trypanosomiasis

Explore clinical trials studying Trypanosomiasis. Study availability and eligibility vary by location and protocol.

71 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Trypanosomiasis trial results

Completed

Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense

NCT03087955

Conditions
Euglenozoa Infections, Gambiense Trypanosomiasis, Infections, +6 more
Locations
  • Centre de Traitement de Nkara Nkara, Bandundu, Democratic Republic of the Congo
  • Centre de Traitement de Kimpese Kimpese, Bas-Congo Province, Democratic Republic of the Congo
  • Hôpital Général de Référence de Ngandajika Gandajika, East Kasai, Democratic Republic of the Congo
  • Hôpital Secondaire de Katanda Katanda, East Kasai, Democratic Republic of the Congo
View Trial Details
Completed

Delivering a Multi-disease Screening Tool to Migrant Populations

NCT05868005

Conditions
Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +45 more
Locations
  • Servicio Andaluz de Salud (SAS) (administration of the participant PCCs in Andalusia) Almería, Andalusia, Spain
  • Institut Català de la Salut (ICS) (administration of the participant PCCs in Catalonia) Tortosa, Catalonia, Spain
View Trial Details
Completed

Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

NCT05256017

Conditions
Euglenozoa Infections, Infections, Parasitic Diseases, +6 more
Locations
  • General Referral Hospital of Bagata Bagata, Bandundu, Democratic Republic of the Congo
  • Hospital of Dipumba Mbuji-Mayi, East Kasai, Democratic Republic of the Congo
  • General Referral Hospital of Idiofa Idiofa, Kwilu, Democratic Republic of the Congo
  • General Referral Hospital of Masi-Manimba Masi-Manimba, Kwilu, Democratic Republic of the Congo
View Trial Details
Completed

A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi

NCT02625974

Conditions
Chagas Disease, Euglenozoa Infections, Infections, +4 more
Locations
  • La Plata, Buenos Aires, Argentina
  • Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
  • Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
  • Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina
View all 25 locations
View Trial Details
Completed

New Therapies and Biomarkers for Chagas Infection

NCT03981523

Conditions
Chagas Disease, Euglenozoa Infections, Infections, +5 more
Locations
  • Platform for the Comprehensive Care of Patients with Chagas Disease Cochabamba, Cercado, Bolivia
  • Platform for the Comprehensive Care of Patients with Chagas Disease Tarija, Cercado, Bolivia
  • Platform for the Comprehensive Care of Patients with Chagas Disease Sucre, Bolivia
View Trial Details
Completed

Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.

NCT03191162

Conditions
Chagas Disease, Euglenozoa Infections, Infections, +5 more
Locations
  • Instituto Nacional de Parasitología Dr. Mario Fatala Chaben (ANLIS) Buenos Aires, Argentina
  • Instituto de Cardiología de Corrientes Juana Francisca Cabral Corrientes, Argentina
  • Centro de Pesquisas René Rachou - Fundação Oswaldo Cruz. (FIOCRUZ) Belo Horizonte, Brazil
  • Hospital Universitário Clemente de Faria Montes Claros, Brazil
View Trial Details

Related conditions